Victoria's Secret (VSCO) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
5 May, 2026Executive summary
Board highlighted 164% total shareholder return since CEO Hillary Super's appointment, significantly outperforming industry benchmarks and peers.
Ongoing execution of the Path to Potential strategy is credited for recent growth and value creation.
Board remains focused on sustaining momentum and maximizing shareholder value.
Voting matters and shareholder proposals
BBRC International and Brett Blundy launched a proxy contest to withhold votes against two directors at the 2026 Annual Meeting.
Board unanimously supports the targeted directors and opposes BBRC's campaign, citing risks associated with Blundy's candidacy.
Board does not intend to extend the short-term shareholder rights plan, which expires May 18, 2026.
Board of directors and corporate governance
Board consists of nine independent directors and CEO Hillary Super, led by independent Chair Donna James.
Board composition balances continuity with fresh perspectives, including three new independent directors since 2022.
Board met 35 times over the past three fiscal years, demonstrating high engagement.
Board conducted a comprehensive review of Blundy's candidacy, identifying reputational, legal, and governance risks.
Latest events from Victoria's Secret
- BBRC seeks board accountability for underperformance, urging votes against two directors and executive pay.VSCO
Proxy filing4 May 2026 - Key votes include director elections, executive pay approval, and auditor ratification.VSCO
Proxy filing1 May 2026 - Strong growth, robust governance, and performance-driven compensation define this year's proxy.VSCO
Proxy filing1 May 2026 - Q4 and 2025 beat guidance with 8% comp sales growth and strong 2026 outlook.VSCO
Q4 20265 Mar 2026 - Q4 and FY 2025 outperformed expectations, with growth in bras, PINK, and beauty driving results.VSCO
Investor presentation5 Mar 2026 - Q3 2024 sales up 7% with improved margins, narrowed loss, and raised outlook.VSCO
Q3 20253 Feb 2026 - Q1 2024 net sales fell 3% to $1.36B, with $9M adjusted net income and strong international growth.VSCO
Q1 20251 Feb 2026 - Operating and net income rebounded, with improved outlook despite a 1% sales decline.VSCO
Q2 202523 Jan 2026 - Q3 sales up 9% with margin expansion and raised full-year guidance across key metrics.VSCO
Q3 20266 Dec 2025